Edition:
United Kingdom

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

432.85INR
19 Jul 2019
Change (% chg)

Rs-8.00 (-1.81%)
Prev Close
Rs440.85
Open
Rs440.80
Day's High
Rs446.80
Day's Low
Rs431.00
Volume
719,816
Avg. Vol
896,277
52-wk High
Rs711.90
52-wk Low
Rs423.65

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Glenn Saldanha

49 2011 Executive Chairman of the Board, Chief Executive Officer, Managing Director

V. S. Mani

2018 Global Chief Financial Officer, Executive Director

Harish Kuber

2017 Compliance Officer, Company Secretary

Cherylann Pinto

Director - Corporate Affairs, Executive Director

Rajesh Desai

52 2017 Non-Executive Director